Doctor with experience in metabolic control of diabetic and hypertensive patients and a diploma in Diabetology. Current Medical Director of GIOSTAR Mexico in Los Algodones Mexicali Baja California since 2017. Graduated from Autonomous University of Guadalajara and has experience in patient admission, external medical service and emergencies in multiple private hospitals.
Read moreDoctor with experience in metabolic control of diabetic and hypertensive patients and a diploma in Diabetology. Current Medical Director of GIOSTAR Mexico in Los Algodones Mexicali Baja California since 2017. Graduated from Autonomous University of Guadalajara and has experience in patient admission, external medical service and emergencies in multiple private hospitals.
Education:
1977 - 1984 - Medical Institute, specialty "Medical business"
Improving skills and acquiring new knowledge:
1990 - Clinical residency in the specialty "Cycle therapy with clinical cardiology", Kyiv
1992 - TU "Medical Radiology", Kharkiv
1995 - TU "Modern methods of diagnosis of internal diseases and rheumatology", Kyiv
1999 - TU "Organization of Medical Support of the Armed Forces", Kyiv
2004 - TU "Current issues of clinical arrhythmology in cardiology", Kyiv
2009 - TU "Current issues of therapy and rheumatology", Kyiv
2012 - TU "Fundamentals of geriatric knowledge", Kyiv
2013 – Institute for Advanced Training of Managerial Personnel of the National Academy of Sciences under the President of Ukraine, Kyiv
2014 - TU "Current issues of therapy and pulmonology", Kyiv
2016 - Specialization "organization and management of health care", Kyiv
2018 - TU "Current issues of internal diseases of the patient", Kyiv
2020 - TU "Current issues of therapy", Kyiv
2021 - TU "Current issues of internal diseases of the patient", Kyiv
2023 - TU "Current issues - clinical cardiology", Kyiv
The main areas of practical activity:
examination, anamnesis study and consultations on the treatment of diseases of a therapeutic profile
appointment of the necessary additional examination
interpretation of analysis results
appointment of an individual treatment plan and recommendations for disease prevention
control of therapy, recovery and rehabilitation measures
Participation in associations:
Association of therapists of Ukraine
Association of Cardiologists of Ukraine
Association of Gastroenterologists of Ukraine
Organization of medical care in EU countries
Association of Physiotherapists ("Karlovo Vary", Prague)
The therapist treats the following diseases:
SARS
acute bronchitis
pneumonia
State Public Enterprise
acute vasomotor rhinitis
chronic gastroduodenitis
ulcer disease
chronic cholecystitis
pancreatitis
NCD
hypertensive disease
CHD
gout
gouty polyarthritis
acute cystitis
metabolic disorders, obesity
Read more
Education:
1977 - 1984 - Medical Institute, specialty "Medical business"
Improving skills and acquiring new knowledge:
1990 - Clinical residency in the specialty "Cycle therapy with clinical cardiology", Kyiv
1992 - TU "Medical Radiology", Kharkiv
1995 - TU "Modern methods of diagnosis of internal diseases and rheumatology", Kyiv
1999 - TU "Organization of Medical Support of the Armed Forces", Kyiv
2004 - TU "Current issues of clinical arrhythmology in cardiology", Kyiv
2009 - TU "Current issues of therapy and rheumatology", Kyiv
2012 - TU "Fundamentals of geriatric knowledge", Kyiv
2013 – Institute for Advanced Training of Managerial Personnel of the National Academy of Sciences under the President of Ukraine, Kyiv
2014 - TU "Current issues of therapy and pulmonology", Kyiv
2016 - Specialization "organization and management of health care", Kyiv
2018 - TU "Current issues of internal diseases of the patient", Kyiv
2020 - TU "Current issues of therapy", Kyiv
2021 - TU "Current issues of internal diseases of the patient", Kyiv
2023 - TU "Current issues - clinical cardiology", Kyiv
The main areas of practical activity:
examination, anamnesis study and consultations on the treatment of diseases of a therapeutic profile
appointment of the necessary additional examination
interpretation of analysis results
appointment of an individual treatment plan and recommendations for disease prevention
control of therapy, recovery and rehabilitation measures
Participation in associations:
Association of therapists of Ukraine
Association of Cardiologists of Ukraine
Association of Gastroenterologists of Ukraine
Organization of medical care in EU countries
Association of Physiotherapists ("Karlovo Vary", Prague)
The therapist treats the following diseases:
SARS
acute bronchitis
pneumonia
State Public Enterprise
acute vasomotor rhinitis
chronic gastroduodenitis
ulcer disease
chronic cholecystitis
pancreatitis
NCD
hypertensive disease
CHD
gout
gouty polyarthritis
acute cystitis
metabolic disorders, obesity
Doctor with over 20 years of experience in physical medicine and rehabilitation, including leading the Rehabilitation Department and Deputy Chief of the Rehabilitation Department. Has a Specialist Certification in Algiatry and Physical Medicine and Rehabilitation, and has completed courses in myoskeletal medicine, medical acupuncture and physical therapy of the pelvic floor. Has published several works in the field of rehabilitation.
Read moreDoctor with over 20 years of experience in physical medicine and rehabilitation, including leading the Rehabilitation Department and Deputy Chief of the Rehabilitation Department. Has a Specialist Certification in Algiatry and Physical Medicine and Rehabilitation, and has completed courses in myoskeletal medicine, medical acupuncture and physical therapy of the pelvic floor. Has published several works in the field of rehabilitation.
Experience
2019 - 2022
University of Health Sciences, Faculty of Medicine, Ankara City Hospital, Cardiology Clinic, Ankara
2017 - 2019
University of Health Sciences, Faculty of Medicine, Turkey Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2012 - 2017
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2012 - 2017
T.R. Karabük University, Faculty of Medicine, Department of Cardiology
2006 - 2006
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2001 - 2006
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
1996 - 2001
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
Education
2017 Karabük University, Faculty of Medicine, Department of Cardiology
2006 Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic
2001 Türkiye Higher Specialization Training and Research Hospital, Ankara, Cardiology
1996 Ankara University, Faculty of Medicine
Read moreExperience
2019 - 2022
University of Health Sciences, Faculty of Medicine, Ankara City Hospital, Cardiology Clinic, Ankara
2017 - 2019
University of Health Sciences, Faculty of Medicine, Turkey Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2012 - 2017
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2012 - 2017
T.R. Karabük University, Faculty of Medicine, Department of Cardiology
2006 - 2006
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
2001 - 2006
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
1996 - 2001
Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,
Education
2017 Karabük University, Faculty of Medicine, Department of Cardiology
2006 Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic
2001 Türkiye Higher Specialization Training and Research Hospital, Ankara, Cardiology
1996 Ankara University, Faculty of Medicine
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Read more
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Experience
2018 - 2022
Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital
2016 - 2018
Diyarbakır Memorial Dicle Hospital Cardiology Clinic
2010 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2010 - 2016
Private Veni Vidi Hospital, Cardiology Clinic Supervisor
2006 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2005 - 2006
Urfa State Hospital
1999 - 2005
Turkey High Specialization Training and Research Hospital
1998 - 1999
Duruca Health Center
Education
2018
Health Sciences University, Cardiology
2010
Dicle University, Department of Cardiology
2005
Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization
1998
Ege University, Faculty of Medicine
Read moreExperience
2018 - 2022
Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital
2016 - 2018
Diyarbakır Memorial Dicle Hospital Cardiology Clinic
2010 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2010 - 2016
Private Veni Vidi Hospital, Cardiology Clinic Supervisor
2006 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2005 - 2006
Urfa State Hospital
1999 - 2005
Turkey High Specialization Training and Research Hospital
1998 - 1999
Duruca Health Center
Education
2018
Health Sciences University, Cardiology
2010
Dicle University, Department of Cardiology
2005
Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization
1998
Ege University, Faculty of Medicine
Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.
Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.
Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988
Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994
Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012
Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.
Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.
Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.
Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.
Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.
Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.
Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.
Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.
Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.
Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988
Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994
Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012
Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.
Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.
Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.
Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.
Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.
Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.
Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.
Education:
2010 - 2016 - National Medical University named after O.O. Bogomolets, specialty "Medical business"
2017 - completed an internship in the field of "Laboratory diagnostics"
2018 - Ukrainian Military Medical Academy, specialty "Dermatovenereology"
2021 - senior lecturer of the department of VZPSM on the course "Dermatovenereology", Ukrainian Military Medical Academy
2021 - certified trainer in injection techniques
Since 2017 - dermatologist, cosmetologist at Mediland MC
Improving skills and acquiring new knowledge:
2017 - courses under the program "Cosmetologist, body esthetician" at the School of Cosmetology and Aesthetic Medicine "Partner +"
2017 - courses under the program "Specialist in injection techniques: mesotherapy, biorevitalization, botulinum therapy, contour plastic surgery"
2017 - participant of the III All-Ukrainian symposium Company of Cosmetology
2018 - course under the "Trichology" program
2018 - course under the program "Plasmotherapy"
2018 - course under the program "Contour plastic in aesthetic medicine"
2018 - course under the program "PRX-T33 - Injection-free dermal remodeling"
2018 - received training in laser techniques "Laser training on: Motus, MINISILK_FT, YNCHRO_FT"
2018 - participant of the 4th All-Ukrainian symposium "Company of Cosmetology"
2020 - "MEDfocus: dialogue of professionals" Modern approaches in dermatology and aesthetic medicine
2020 - "DERM SUMMIT" International scientific and practical virtual summit for doctors of all specialties and patients on dermatology issues
2021 - "Melanoma days 2021"
2021- "Acne, rosacea and chronic dermatoses of the face" as part of the 2021 Spring Symposium.
2021 - "Academy of Trichology"
2021 - "S-congress 3.0"
2021 - "Advanced dermatology: multifaceted possibilities and solutions"
2022 - academic readings named after Volodymyr Pask within the framework of the 31st International Medical Exhibition "PUBLIC HEALTH 2022"
2022 - "MELANOMA DAY 2022"
Is a valid member:
Ukrainian Association of Dermatologists and Cosmetologists UADVC
International Association of Aesthetic Cosmetology and Mesotherapy MAEKM
The doctor is an expert in the TV project "I am ashamed of my body" (STB channel) - he conducts consultations, diagnoses and treats patients, the heroes of the project.
Certified trainer in injection techniques of the MedHome company for Twac and Phillex drugs.Senior lecturer of the Department of the Ukrainian Academy of Medical Sciences for the course "Dermatovenereology", Ukrainian Military Medical Academy
A trichologist, dermatologist diagnoses and treats such diseases of the skin of the face and body, nails and hair as:
acne skin irritations, acne, postacne
rosacea
demodicosis
seborrheic dermatitis
skin neoplasms - warts, papillomas, etc
alopecia or hair loss of various types (examination using a trichoscope and laboratory tests, prescription of conservative treatment, treatment using injection methods of treatment)
onychomycosis or nail fungus
other diseases of the skin of the face, body, hair
Performed procedures for diagnosis and treatment of dermatological diseases:
Dermatoscopy
Radiowave removal of skin neoplasms with the Surgitron device
Cryodestruction of skin neoplasms - warts, papillomas
Cryomassage of the skin of the face, body and scalp
Trichoscopy of the scalp and hair follicles
The doctor will draw up an individual comprehensive skin care program depending on the type of skin and its condition
The cosmetologist performs the following procedures:
Laser cosmetology:
laser epilation
laser grinding
photo rejuvenation
carbon peeling
Classical cosmetology:
mechanical cleaning of the face
ultrasonic face cleaning
chemical peels
facial massage
carboxytherapy
skin care procedures
comprehensive skin care programs
Hardware cosmetology:
procedures on "Futura PRO"
Ultrasonic facial massage
microcurrent
myostimulation of the face and body
biostimulation of the face and body
darsonval of the face and scalp
Injection cosmetology:
mesotherapy of the face, body and scalp / hair
biorevitalization
revitalization "Aquashine"
botulinum therapy
contour plastic
plasma lifting or PRP therapy
Cryotherapy:
cryomassage of the skin of the face, décolleté, back
cryomassage of the scalp
Read more
Education:
2010 - 2016 - National Medical University named after O.O. Bogomolets, specialty "Medical business"
2017 - completed an internship in the field of "Laboratory diagnostics"
2018 - Ukrainian Military Medical Academy, specialty "Dermatovenereology"
2021 - senior lecturer of the department of VZPSM on the course "Dermatovenereology", Ukrainian Military Medical Academy
2021 - certified trainer in injection techniques
Since 2017 - dermatologist, cosmetologist at Mediland MC
Improving skills and acquiring new knowledge:
2017 - courses under the program "Cosmetologist, body esthetician" at the School of Cosmetology and Aesthetic Medicine "Partner +"
2017 - courses under the program "Specialist in injection techniques: mesotherapy, biorevitalization, botulinum therapy, contour plastic surgery"
2017 - participant of the III All-Ukrainian symposium Company of Cosmetology
2018 - course under the "Trichology" program
2018 - course under the program "Plasmotherapy"
2018 - course under the program "Contour plastic in aesthetic medicine"
2018 - course under the program "PRX-T33 - Injection-free dermal remodeling"
2018 - received training in laser techniques "Laser training on: Motus, MINISILK_FT, YNCHRO_FT"
2018 - participant of the 4th All-Ukrainian symposium "Company of Cosmetology"
2020 - "MEDfocus: dialogue of professionals" Modern approaches in dermatology and aesthetic medicine
2020 - "DERM SUMMIT" International scientific and practical virtual summit for doctors of all specialties and patients on dermatology issues
2021 - "Melanoma days 2021"
2021- "Acne, rosacea and chronic dermatoses of the face" as part of the 2021 Spring Symposium.
2021 - "Academy of Trichology"
2021 - "S-congress 3.0"
2021 - "Advanced dermatology: multifaceted possibilities and solutions"
2022 - academic readings named after Volodymyr Pask within the framework of the 31st International Medical Exhibition "PUBLIC HEALTH 2022"
2022 - "MELANOMA DAY 2022"
Is a valid member:
Ukrainian Association of Dermatologists and Cosmetologists UADVC
International Association of Aesthetic Cosmetology and Mesotherapy MAEKM
The doctor is an expert in the TV project "I am ashamed of my body" (STB channel) - he conducts consultations, diagnoses and treats patients, the heroes of the project.
Certified trainer in injection techniques of the MedHome company for Twac and Phillex drugs.Senior lecturer of the Department of the Ukrainian Academy of Medical Sciences for the course "Dermatovenereology", Ukrainian Military Medical Academy
A trichologist, dermatologist diagnoses and treats such diseases of the skin of the face and body, nails and hair as:
acne skin irritations, acne, postacne
rosacea
demodicosis
seborrheic dermatitis
skin neoplasms - warts, papillomas, etc
alopecia or hair loss of various types (examination using a trichoscope and laboratory tests, prescription of conservative treatment, treatment using injection methods of treatment)
onychomycosis or nail fungus
other diseases of the skin of the face, body, hair
Performed procedures for diagnosis and treatment of dermatological diseases:
Dermatoscopy
Radiowave removal of skin neoplasms with the Surgitron device
Cryodestruction of skin neoplasms - warts, papillomas
Cryomassage of the skin of the face, body and scalp
Trichoscopy of the scalp and hair follicles
The doctor will draw up an individual comprehensive skin care program depending on the type of skin and its condition
The cosmetologist performs the following procedures:
Laser cosmetology:
laser epilation
laser grinding
photo rejuvenation
carbon peeling
Classical cosmetology:
mechanical cleaning of the face
ultrasonic face cleaning
chemical peels
facial massage
carboxytherapy
skin care procedures
comprehensive skin care programs
Hardware cosmetology:
procedures on "Futura PRO"
Ultrasonic facial massage
microcurrent
myostimulation of the face and body
biostimulation of the face and body
darsonval of the face and scalp
Injection cosmetology:
mesotherapy of the face, body and scalp / hair
biorevitalization
revitalization "Aquashine"
botulinum therapy
contour plastic
plasma lifting or PRP therapy
Cryotherapy:
cryomassage of the skin of the face, décolleté, back
cryomassage of the scalp
Dr. Roberto Franco Carlo Mella
Medical Group Coordinator & Physician at Satori Recovery
Dr. Roberto Mella brings over 20 years of diverse and extensive medical experience to Satori Recovery. Born in Brussels and multilingual in English, German, Spanish, Italian, and French, he is a seasoned medical professional with a truly global perspective. His career spans military and civilian medicine, from serving as a naval doctor for the German Navy to practicing as an anesthesiologist and emergency response physician in leading medical institutions across Europe.
Dr. Mella’s expertise is complemented by his entrepreneurial ventures, including founding medical service and consulting enterprises such as the German Dream Team. His specialized training includes anesthesiology, hyperbaric and diving medicine, osteopathy, and medical quality management. His passion for holistic care makes him an exceptional guide for Satori’s mission to provide transformative recovery experiences.
In addition to his professional accomplishments, Dr. Mella's personal journey reflects a deep commitment to growth and learning. As a mentor, teacher, and advocate for lifelong education, he combines clinical expertise with empathetic leadership, embodying the values of excellence and compassion central to Satori Recovery.
Read moreDr. Roberto Franco Carlo Mella
Medical Group Coordinator & Physician at Satori Recovery
Dr. Roberto Mella brings over 20 years of diverse and extensive medical experience to Satori Recovery. Born in Brussels and multilingual in English, German, Spanish, Italian, and French, he is a seasoned medical professional with a truly global perspective. His career spans military and civilian medicine, from serving as a naval doctor for the German Navy to practicing as an anesthesiologist and emergency response physician in leading medical institutions across Europe.
Dr. Mella’s expertise is complemented by his entrepreneurial ventures, including founding medical service and consulting enterprises such as the German Dream Team. His specialized training includes anesthesiology, hyperbaric and diving medicine, osteopathy, and medical quality management. His passion for holistic care makes him an exceptional guide for Satori’s mission to provide transformative recovery experiences.
In addition to his professional accomplishments, Dr. Mella's personal journey reflects a deep commitment to growth and learning. As a mentor, teacher, and advocate for lifelong education, he combines clinical expertise with empathetic leadership, embodying the values of excellence and compassion central to Satori Recovery.